COVID-19 Vaccination: Guidance for Ethical, Informed Consent in a National Context

Area of Science:

• Medical Ethics
• Public Health Policy
• Vaccinology

Background:

• Informed consent for novel, provisionally registered COVID-19 vaccines presents unique ethical challenges.
• The pandemic context can pressure healthcare providers and patients, potentially compromising valid informed consent.
• International data analysis and presentation by government agencies highlight the global relevance of informed consent for COVID-19 vaccines.

Purpose of the Study:

• To provide guidance on ethically obtaining informed consent for COVID-19 vaccines, considering both knowns and unknowns.
• To assist family physicians in addressing patient concerns regarding COVID-19 disease and vaccines.
• To facilitate personalized risk-benefit assessments for vaccine recipients.

Main Methods:

• Reviewed Public Assessment Reports from regulatory authorities (FDA, TGA) and published vaccine trials.
• Observed international COVID-19 vaccine safety discussions, referencing peer-reviewed and pre-print literature.
• Examined Vaccine Development Guidelines and compared pre-clinical data with licensing information.

Main Results:

• Identified pertinent unknowns relevant to informed consent, highlighting disparities with standard government advice.
• Structured key issues into a twelve-point framework for ethical informed consent discussions.
• Briefly addressed pediatric COVID-19 disease and vaccination, noting its unapproved status in certain age groups.

Conclusions:

• Ethically obtained, fully informed consent is crucial for investigational vaccines, even during a pandemic.
• Physicians can bridge the information gap between official guidance and patient concerns through structured discussions.
• Consent must be voluntary, free from coercion, respecting human rights and individual judgment regarding available information.